<DOC>
	<DOCNO>NCT01453751</DOCNO>
	<brief_summary>This open-label , non-randomized , multi-center , patient sponsor study Adipose-Derived Stromal vascular fraction cell implantation via intravenous infusion . The intent clinical study answer question : 1 ) Is propose treatment safe 2 ) Is treatment effective improve disease pathology patient diagnose Type II Diabetes Mellitus .</brief_summary>
	<brief_title>Safety Effects Autologous Adipose-Derived Stromal Cells Delivered Patients With Type II Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Males Females Age 18 80 year . Type 2 diabetes mellitus ( guideline WHO , 1999 ) ; Body mass index ( BMI ) ≤35㎏/㎡ ; Fast blood glucose ( FBG ) ≥7.0 mmol/L , Hemoglobin A1c ( HgbA1c ) ≥7％ ; Up date age gender appropriate cancer screen per American Cancer Society . Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Life expectancy &lt; 6 month due concomitant illness . Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . If patient test positive , consulted patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) ≤90 mmHg &gt; 180mmHg Resting heart rate &gt; 100 bpm ; Active clinical infection within one week enrollment . Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Unwilling and/or able give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Type 2 Diabetes</keyword>
</DOC>